🇺🇸 FDA

Drug profile · INN

solriamfetol

SUNOSI

approved N06BA14
US status
approved
Patents linked
8
News articles
0

Quick answer

solriamfetol (SUNOSI) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

Key facts

INN solriamfetol
Brand SUNOSI
Formulation TABLET
ATC code N06BA14

Related patents

Search patents →

  1. US 12318362

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12263145

    Methods of administering solriamfetol to lactating women

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12194016

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12102609

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12090126

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12064411

    Methods of administering solriamfetol to lactating women

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12036194

    Methods of administering solriamfetol to lactating women

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12005036

    Methods of administering solriamfetol to lactating women

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is solriamfetol?

solriamfetol (SUNOSI) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

What is the brand name for solriamfetol?

SUNOSI is a marketed brand name for solriamfetol. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of solriamfetol?

solriamfetol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.